Paradigm Capital Analyst Discusses First Biosynthetics Cannabis Conference



Paradigm Capital Equities Analyst for Healthcare and Biotechnology, Rahul Sarugaser, discusses the company’s biosynthetics cannabis conference on April 15, …

Be the first to comment

Leave a Reply

Your email address will not be published.


*